Drug Database
Back to search

United States· US:60771-0001_519cf0bd-738a-cd84-e063-6294a90ab373

MELAO TALLOW SUNSCREEN

A medicinal product containing .beta.-bisabolol; tallow acid, beef; ethyl methoxycinnamate; saururus chinensis flower; stephania tetrandra whole; peg-9 diglycidyl ether/sodium hyaluronate crosspolymer; tocopheryl retinoate, registered in United States by Guangzhou Haishi Biological Technology Co., Ltd..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMELAO TALLOW SUNSCREENATC—REGISTER NO.US:60771-0001_519cf0b…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about .beta.-bisabolol; tallow acid, beef; ethyl methoxycinnamate; saururus chinensis flower; stephania tetrandra whole; peg-9 diglycidyl ether/sodium hyaluronate crosspolymer; tocopheryl retinoateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
.BETA.-BISABOLOL; TALLOW ACID, BEEF; ETHYL METHOXYCINNAMATE; SAURURUS CHINENSIS FLOWER; STEPHANIA TETRANDRA WHOLE; PEG-9 DIGLYCIDYL ETHER/SODIUM HYALURONATE CROSSPOLYMER; TOCOPHERYL RETINOATE
Manufacturer
Guangzhou Haishi Biological Technology Co., Ltd.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    60771-0001-1
  • ndc11
    6077100011
    60 g in 1 JAR (60771-0001-1)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f40c2491-328d-472b-a189-58cd136521db
GET /v1/drugs/f40c2491-328d-472b-a189-58cd136521db?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": ".3; 5; 4; 2; .1; .2; 1",
  "substance": ".BETA.-BISABOLOL; TALLOW ACID, BEEF; ETHYL METHOXYCINNAMATE; SAURURUS CHINENSIS FLOWER; STEPHANIA TETRANDRA WHOLE; PEG-9 DIGLYCIDYL ETHER/SODIUM HYALURONATE CROSSPOLYMER; TOCOPHERYL RETINOATE",
  "productndc": "60771-0001",
  "dosage_form": "CREAM",
  "dea_schedule": null,
  "strength_unit": "g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g",
  "application_number": "M020",
  "marketing_category": "OTC MONOGRAPH DRUG"
}
API referenceMCP serverPlans

See everything about .beta.-bisabolol; tallow acid, beef; ethyl methoxycinnamate; saururus chinensis flower; stephania tetrandra whole; peg-9 diglycidyl ether/sodium hyaluronate crosspolymer; tocopheryl retinoate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console